Patients with COVID-19 Pneumonia Treated with the Standard Protocol: Observational Results of Five Intensive Care Units
PDF
Cite
Share
Request
Original Research
P: 1-13
March 2020

Patients with COVID-19 Pneumonia Treated with the Standard Protocol: Observational Results of Five Intensive Care Units

J Turk Soc Intens Care 2020;18(1):1-13
1. Acıbadem Sağlık Grubu Altunizade Acıbadem Hastanesi, Yoğun Bakım Kliniği, İstanbul, Türkiye
2. Mehmet Ali Aydınlar Acıbadem Üniversitesi Tıp Fakültesi, Anesteziyoloji ve Reanimasyon Anabilim Dalı, İstanbul
3. Zeynep Tuğçe Sarıkaya, Emir Kılınç, Seher İrem Kıran, Merve Şeker
4. Acıbadem Sağlık Grubu Altunizade Acıbadem Hastanesi, Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Kliniği, İstanbul, Türkiye
5. Mehmet Ali Aydınlar Acıbadem Üniversitesi Tıp Fakültesi, Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Anabilim Dalı, İstanbul, Türkiye
6. Acıbadem Sağlık Grubu Kozyatağı Acıbadem Hastanesi, Yoğun Bakım Kliniği, İstanbul, Türkiye
7. Acıbadem Sağlık Grubu Taksim Acıbadem Hastanesi, Yoğun Bakım Kliniği, İstanbul, Türkiye
8. Acıbadem Sağlık Grubu Maslak Acıbadem Hastanesi, Yoğun Bakım Kliniği, İstanbul, Türkiye
9. Acıbadem Sağlık Grubu Fulya Acıbadem Hastanesi, Yoğun Bakım Kliniği, İstanbul, Türkiye
10. İstanbul Üniversitesi, İstanbul Tıp Fakültesi, Anesteziyoloji ve Reanimasyon Anabilim Dalı, İstanbul, Türkiye
No information available.
No information available
Received Date: 29.05.2020
Accepted Date: 21.07.2020
Publish Date: 14.10.2020
PDF
Cite
Share
Request

ABSTRACT

Objective:

The number of patients with COVID-19 has rapidly increased, thereby exceeding the capacities of health systems and causing serious losses in affected countries because of the rapid spreading potential, high virulence, and lack of vaccine and proven antiviral therapy. This may indicate the importance of protocol-based treatments in maintaining the treatment process accurately, with minimal errors. This study aimed to present the results of a protocol-based treatment prepared in accordance with the “Surviving Sepsis Campaign COVID-19 treatment guideline.”

Materials And Methods:

This retrospective and prospective study used data of five hospitals. Intensive care and treatment approaches were carried out in accordance with the “COVID-19 approach protocol” prepared according to the “Surviving Sepsis Campaign COVID-19 treatment guideline.”

Results:

A total of 1143 patients admitted to five hospitals were hospitalized with a prediagnosis of COVID-19, and 115 patients needed intensive care. Among them, patients without COVID-19 were excluded and the remaining 77 patients were evaluated. In this study, 9 (11.7%) of the 77 patients were lost. While the mortality rate did not differ by sex (p=0.661), the mean age of deceased patients was significantly higher (p=0.006). Considering their comorbidities, the mortality rates of patients with hypertension, chronic renal failure, and cancer were significantly higher (p=0.034, p=0.014, and p=0.007, respectively).

Conclusion:

The mortality rate in this series may suggest that the treatments performed in line with the “Survival in Sepsis Campaign COVID-19 treatment guideline” are useful. However, when the causes of mortality and morbidity were evaluated, good observation of neurological, infective, respiratory, and immune complications may be considered the main factor in reducing mortality and should be included in the guideline.

Keywords: COVID-19, ARDS, mechanical ventilation, prone position, sepsis, Turkey

References

1
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med 2020;382:727‐33.
2
Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 2020;5:536-44.
3
World Health Organization. Rolling Updates on Coronavirus Disease (Covid-19) Available from: URL: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen
4
Spina S, Marrazzo F, Migliari M, Stucchi R, Sforza A, Fumagalli R. The response of Milan’s Emergency Medical System to the COVID-19 outbreak in Italy. Lancet 2020;395:e49-50.
5
Grasselli G, Pesenti A, Cecconi M. Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast During an Emergency Response. JAMA 2020;323:1545-6. [published online ahead of print, 2020 Mar 13]
6
Xie J, Tong Z, Guan X, Du B, Qiu H, Slutsky AS. Critical care crisis and some recommendations during the COVID-19 epidemic in China. Intensive Care Med 2020;46:837-40.
7
Kluge S, Janssens U, Welte T, Weber-Carstens S, Marx G, Karagiannidis C. German recommendations for critically ill patients with COVID‑19. Med Klin Intensivmed Notfmed 2020:1-4. [published online ahead of print, 2020 Apr 14]
8
Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA 2020;323:1239-42. [published online ahead of print, 2020 Feb 24]
9
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020;382:1708-20.
10
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA 2020;323:1061-9. [published online ahead of print, 2020 Feb 7]
11
Li X, Ma X. Acute respiratory failure in COVID-19: is it “typical” ARDS? Crit Care 2020;24. [Published 2020 May 6]
12
ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA 2012;307:2526-2533.
13
Gattinoni L, Chiumello D, Rossi S. COVID-19 pneumonia: ARDS or not? Crit Care 2020;24.
14
Alhazzani W, Møller MH, Arabi YM, Loeb M, Gong M, Fan E, et al. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med 2020;46:854-87. 
15
Du Y, Tu L, Zhu P, Mu M, Wang R, Yang P, et al. Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan. A Retrospective Observational Study. Am J Respir Crit Care Med 2020;201:1372-9.
16
Gattinoni L, Meissner K, Marini JJ. The baby lung and the COVID-19 era. Intensive Care Med 2020;46:1438-40. [published online ahead of print, 2020 May 25]
17
Xu Q, Wang T, Qin X, Jie Y, Zha L, Lu W. Early awake prone position combined with high-flow nasal oxygen therapy in severe COVID-19: a case series. Crit Care 2020;24. [Published 2020 May 24]
18
Ng Z, Tay WC, Ho CHB. Awake Prone Positioning for Non-intubated Oxygen Dependent COVID-19 Pneumonia Patients. Eur Respir J 2020;56:2001198. [published online ahead of print, 2020 May 26]
19
Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 2020;395:1033-4.
20
Spiezia L, Boscolo A, Poletto F, Cerruti L, Tiberio I, Campello E, et al. COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure. Thromb Haemost 2020;120:998-1000.
21
Ranucci M, Ballotta A, Di Dedda U, Bayshnikova E, Poli MD, Resta M, et al. The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome. J Thromb Haemost 2020;18:1747-51. [published online ahead of print, 2020 Apr 17]
2024 ©️ Galenos Publishing House